长城医药产业精选混合发起式C(022287)申购赎回 |
|
|
| 报告期 |
期初总份额(份) |
期末总份额(份) |
期间总申购份额(份) |
期间总赎回份额(份) |
期间净申赎份额(份) |
净申赎比例 |
| 2026/6/30 |
1,112,800,000 |
836,755,000 |
1,865,810,000 |
2,141,850,000 |
-276,040,000 |
-24.81% |
| 2026/6/30 |
1,083,950,000 |
836,755,000 |
921,601,000 |
1,168,790,000 |
-247,189,000 |
-22.8% |
| 2026/3/31 |
1,112,800,000 |
1,083,950,000 |
944,205,000 |
973,058,000 |
-28,853,000 |
-2.59% |
| 2025/12/31 |
1,539,790 |
1,112,800,000 |
5,248,400,000 |
4,137,140,000 |
1,111,260,000 |
72169.58% |
| 2025/12/31 |
734,739,000 |
1,112,800,000 |
1,303,430,000 |
925,375,000 |
378,055,000 |
51.45% |
| 2025/9/30 |
556,514,000 |
734,739,000 |
2,198,520,000 |
2,020,290,000 |
178,230,000 |
32.03% |
| 2025/6/30 |
1,539,790 |
556,514,000 |
1,746,440,000 |
1,191,470,000 |
554,970,000 |
36041.93% |
| 2025/6/30 |
13,205,600 |
556,514,000 |
1,731,770,000 |
1,188,460,000 |
543,310,000 |
4114.24% |
| 2025/3/31 |
1,539,790 |
13,205,600 |
14,673,800 |
3,007,980 |
11,665,820 |
757.62% |
| 2024/12/31 |
1,074,810 |
1,539,790 |
471,765 |
6,777 |
464,988 |
43.26% |
| 2024/12/31 |
1,074,810 |
1,539,790 |
471,765 |
6,777 |
464,988 |
43.26% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。